|
1
|
Liu B, Yip R and Zhou Z: Chromatin
remodeling, DNA damage repair and aging. Curr Genomics. 13:533–547.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Soria G, Polo SE and Almouzni G: Prime,
repair, restore: The active role of chromatin in the DNA damage
response. Mol Cell. 46:722–734. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Price BD and D'Andrea AD: Chromatin
remodeling at DNA double-strand breaks. Cell. 152:1344–1354. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zou JX, Guo L, Revenko AS, Tepper CG, Gemo
AT, Kung HJ and Chen HW: Androgen-induced coactivator ANCCA
mediates specific androgen receptor signaling in prostate cancer.
Cancer Res. 69:3339–3346. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zou JX, Revenko AS, Li LB, Gemo AT and
Chen HW: ANCCA, an estrogen-regulated AAA+ ATPase coactivator for
ERalpha, is required for coregulator occupancy and chromatin
modification. Proc Natl Acad Sci USA. 104:18067–18072. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kalashnikova EV, Revenko AS, Gemo AT,
Andrews NP, Tepper CG, Zou JX, Cardiff RD, Borowsky AD and Chen HW:
ANCCA/ATAD2 overexpression identifies breast cancer patients with
poor prognosis, acting to drive proliferation and survival of
triple-negative cells through control of B-Myb and EZH2. Cancer
Res. 70:9402–9412. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Caron C, Lestrat C, Marsal S, Escoffier E,
Curtet S, Virolle V, Barbry P, Debernardi A, Brambilla C, Brambilla
E, et al: Functional characterization of ATAD2 as a new
cancer/testis factor and a predictor of poor prognosis in breast
and lung cancers. Oncogene. 29:5171–5181. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ciro M, Prosperini E, Quarto M, Grazini U,
Walfridsson J, McBlane F, Nucifero P, Pacchiana G, Capra M,
Christensen J and Helin K: ATAD2 is a novel cofactor for MYC,
overexpressed and amplified in aggressive tumors. Cancer Res.
69:8491–8498. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang M, Zhang C, Du W, Yang X and Chen Z:
ATAD2 is overexpressed in gastric cancer and serves as an
independent poor prognostic biomarker. Clin Transl Oncol.
18:776–781. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang J, Huang J, Luo L, Chen Z, Guo Y and
Guo L: Significance of PRO2000/ANCCA expression, a novel
proliferation-associated protein in hepatocellular carcinoma.
Cancer Cell Int. 14:332014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Krakstad C, Tangen IL, Hoivik EA, Halle
MK, Berg A, Werner HM, Ræder MB, Kusonmano K, Zou JX, Øyan AM, et
al: ATAD2 overexpression links to enrichment of B-MYB-translational
signatures and development of aggressive endometrial carcinoma.
Oncotarget. 6:28440–28452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hwang HW, Ha SY, Bang H and Park CK: ATAD2
as a poor prognostic marker for hepatocellular carcinoma after
curative resection. Cancer Res Treat. 47:853–861. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shang P, Meng F, Liu Y and Chen X:
Overexpression of ANCCA/ATAD2 in endometrial carcinoma and its
correlation with tumor progression and poor prognosis. Tumour Biol.
36:4479–4485. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zheng L, Li T, Zhang Y, Guo Y, Yao J, Dou
L and Guo K: Oncogene ATAD2 promotes cell proliferation, invasion
and migration in cervical cancer. Oncol Rep. 33:2337–2344. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Revenko AS, Kalashnikova EV, Gemo AT, Zou
JX and Chen HW: Chromatin loading of E2F-MLL complex by
cancer-associated coregulator ANCCA via reading a specific histone
mark. Mol Cell Biol. 30:5260–5272. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang J, Yang J, Lei Y, Gao H, Wei T, Luo
L, Zhang F, Chen H, Zeng Q and Guo L: An
ANCCA/PRO2000-miR-520a-E2F2 regulatory loop as a driving force for
the development of hepatocellular carcinoma. Oncogenesis.
5:e2292016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Koo SJ, Fernández-Montalván AE, Badock V,
Ott CJ, Holton SJ, von Ahsen O, Toedling J, Vittori S, Bradner JE
and Gorjánácz M: ATAD2 is an epigenetic reader of newly synthesized
histone marks during DNA replication. Oncotarget. 7:70323–70335.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bamborough P, Chung CW, Furze RC, Grandi
P, Michon AM, Watson RJ, Mitchell DJ, Barnett H, Prinjha RK, Rau C,
et al: Aiming to miss a moving target: Bromo and extra terminal
domain (BET) selectivity in constrained ATAD2 inhibitors. J Med
Chem. 61:8321–8336. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fernández-Montalván AE, Berger M, Kuropka
B, Koo SJ, Badock V, Weiske J, Puetter V, Holton SJ, Stöckigt D,
Ter Laak A, et al: Isoform-selective ATAD2 chemical probe with
novel chemical structure and unusual mode of action. ACS Chem Biol.
12:2730–2736. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lord CJ and Ashworth A: The DNA damage
response and cancer therapy. Nature. 481:287–294. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Altieri F, Grillo C, Maceroni M and
Chichiarelli S: DNA damage and repair: From molecular mechanisms to
health implications. Antioxid Redox Signal. 10:891–937. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fong YW, Cattoglio C and Tjian R: The
intertwined roles of transcription and repair proteins. Mol Cell.
52:291–302. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Biswas AK and Johnson DG: Transcriptional
and nontranscriptional functions of E2F1 in response to DNA damage.
Cancer Res. 72:13–17. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hauer MH and Gasser SM: Chromatin and
nucleosome dynamics in DNA damage and repair. Genes Dev.
31:2204–2221. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pei H, Zhang L, Luo K, Qin Y, Chesi M, Fei
F, Bergsagel PL, Wang L, You Z and Lou Z: MMSET regulates histone
H4K20 methylation and 53BP1 accumulation at DNA damage sites.
Nature. 470:124–128. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li X, Baek G, Ramanand SG, Sharp A, Gao Y,
Yuan W, Welti J, Rodrigues DN, Dolling D, Figueiredo I, et al: BRD4
promotes DNA repair and mediates the formation of TMPRSS2-ERG gene
rearrangements in prostate cancer. Cell Rep. 22:796–808. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Floyd SR, Pacold ME, Huang Q, Clarke SM,
Lam FC, Cannell IG, Bryson BD, Rameseder J, Lee MJ, Blake EJ, et
al: The bromodomain protein Brd4 insulates chromatin from DNA
damage signalling. Nature. 498:246–250. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang J, Zou JX, Xue X, Cai D, Zhang Y,
Duan Z, Xiang Q, Yang JC, Louie MC, Borowsky AD, et al: ROR-γ
drives androgen receptor expression and represents a therapeutic
target in castration-resistant prostate cancer. Nat Med.
22:488–496. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chan N, Koritzinsky M, Zhao H, Bindra R,
Glazer PM, Powell S, Belmaaza A, Wouters B and Bristow RG: Chronic
hypoxia decreases synthesis of homologous recombination proteins to
offset chemoresistance and radioresistance. Cancer Res. 68:605–614.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Luoto KR, Meng AX, Wasylishen AR, Zhao H,
Coackley CL, Penn LZ and Bristow RG: Tumor cell kill by c-MYC
depletion: Role of MYC-regulated genes that control DNA
double-strand break repair. Cancer Res. 70:8748–8759. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Boeing S, Williamson L, Encheva V, Gori I,
Saunders RE, Instrell R, Aygün O, Rodriguez-Martinez M, Weems JC,
Kelly GP, et al: Multiomic analysis of the UV-induced DNA damage
response. Cell Rep. 15:1597–1610. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Christmann M and Kaina B: Transcriptional
regulation of human DNA repair genes following genotoxic stress:
Trigger mechanisms, inducible responses and genotoxic adaptation.
Nucleic Acids Res. 41:8403–8420. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
De Siervi A, De Luca P, Byun JS, Di LJ,
Fufa T, Haggerty CM, Vazquez E, Moiola C, Longo DL and Gardner K:
Transcriptional autoregulation by BRCA1. Cancer Res. 70:532–542.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang J, Zuo J, Wang M, Ma X, Gao K, Bai X,
Wang N, Xie W and Liu H: Pololike kinase 4 promotes tumorigenesis
and induces resistance to radiotherapy in glioblastoma. Oncol Rep.
41:2159–2167. 2019.PubMed/NCBI
|
|
35
|
Morozumi Y, Boussouar F, Tan M, Chaikuad
A, Jamshidikia M, Colak G, He H, Nie L, Petosa C, de Dieuleveult M,
et al: Atad2 is a generalist facilitator of chromatin dynamics in
embryonic stem cells. J Mol Cell Biol. 8:349–362. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zou JX, Duan Z, Wang J, Sokolov A, Xu J,
Chen CZ, Li JJ and Chen HW: Kinesin family deregulation coordinated
by bromodomain protein ANCCA and histone methyltransferase MLL for
breast cancer cell growth, survival, and tamoxifen resistance. Mol
Cancer Res. 12:539–549. 2014. View Article : Google Scholar : PubMed/NCBI
|
